Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Factors That Affect Skeletal Responses to PTH
NCT00086619Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2004
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of teriparatide in postmenopausal osteoporosis (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Changes in Indices of Bone Turnover at 18 months. Started May 2004; status: completed.
02
Drugs
teriparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00086619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086619.